127 related articles for article (PubMed ID: 37545272)
1. MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer.
Pan L; Liu W; Zhao H; Chen B; Yue X
Technol Health Care; 2023; 31(6):2251-2265. PubMed ID: 37545272
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-21-5p Accelerates EMT and Inhibits Apoptosis of Laryngeal Carcinoma via Inhibiting KLF6 Expression.
Xu Y
Biochem Genet; 2023 Feb; 61(1):101-115. PubMed ID: 35761154
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
6. Al-MPS Obstructs EMT in Breast Cancer by Inhibiting Lipid Metabolism via miR-215-5p/SREBP1.
Wu CL; Xu LL; Peng J; Zhang DH
Endocrinology; 2022 May; 163(5):. PubMed ID: 35366327
[TBL] [Abstract][Full Text] [Related]
7. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
[TBL] [Abstract][Full Text] [Related]
9. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.
Zheng Y; Zhu K; Wang G
Clin Exp Metastasis; 2022 Aug; 39(4):603-621. PubMed ID: 35449340
[TBL] [Abstract][Full Text] [Related]
10. CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR-625-5p.
Shi G; Li H; Chen Y; Chen Z; Lin X
Thorac Cancer; 2024 Apr; 15(10):808-819. PubMed ID: 38409914
[TBL] [Abstract][Full Text] [Related]
11. MiR-200c-3p aggravates gastric cell carcinoma via KLF6.
Wang Y; Lu K; Li W; Wang Z; Ding J; Zhu Z; Li Z
Genes Genomics; 2021 Nov; 43(11):1307-1316. PubMed ID: 34524611
[TBL] [Abstract][Full Text] [Related]
12. Sevoflurane Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Breast Cancer Cells Through the miR-139-5p/ARF6 Axis.
Wu T; Sun L; Wang C; Yu P; Cheng L; Chen Y
J Surg Res; 2021 Feb; 258():314-323. PubMed ID: 33317757
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway.
Liang Z; Liu L; Gao R; Che C; Yang G
Cell Mol Biol Lett; 2022 Oct; 27(1):88. PubMed ID: 36210461
[TBL] [Abstract][Full Text] [Related]
15. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer.
Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189
[TBL] [Abstract][Full Text] [Related]
17. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
Wang X; Zhou X; Zeng F; Wu X; Li H
Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
[TBL] [Abstract][Full Text] [Related]
18. MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
Wang L; Guo Z; Zhang S; Zhang X; Sang M; Liu Y; Shan B
Altern Ther Health Med; 2023 Jan; 29(1):137-143. PubMed ID: 35986741
[TBL] [Abstract][Full Text] [Related]
19. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
[TBL] [Abstract][Full Text] [Related]
20. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.
Shi XY; Wang H; Wang W; Gu YH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2847-2855. PubMed ID: 31002135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
